A fatal case of mucocutaneous leishmaniasis after pentavalent antimonial use

The authors report a case of mucocutaneous leishmaniasis in a 45-year-old patient who was unsuccessfully treated with pentavalent antimonial for 30 days. After 10 days from the initial treatment and before starting a new therapeutic regimen with the same drug the patient died due to sudden cardiac a...

Full description

Saved in:
Bibliographic Details
Published in:Revista da Sociedade Brasileira de Medicina Tropical 2005-05, Vol.38 (3), p.258
Main Authors: Oliveira, Márcio Campos, Amorim, Rivadávio Fernandes Batista de, Freitas, Roseana de Almeida, Costa, Antonio de Lisboa Lopes
Format: Article
Language:eng ; por
Subjects:
Antiprotozoal Agents - adverse effects
Death, Sudden, Cardiac - etiology
Fatal Outcome
Humans
Leishmaniasis, Mucocutaneous - drug therapy
Male
Meglumine - adverse effects
Meglumine Antimoniate
Middle Aged
Nose Diseases - drug therapy
Nose Diseases - etiology
Oral Ulcer - drug therapy
Oral Ulcer - etiology
Organometallic Compounds - adverse effects
Vector-borne diseases
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The authors report a case of mucocutaneous leishmaniasis in a 45-year-old patient who was unsuccessfully treated with pentavalent antimonial for 30 days. After 10 days from the initial treatment and before starting a new therapeutic regimen with the same drug the patient died due to sudden cardiac arrest.
ISSN:0037-8682
1678-9849
DOI:10.1590/S0037-86822005000300011